Pub Date : 2022-01-27DOI: 10.29245/2572-9411/2022/1.1203
B. Dua, Rajaram Sharma, T. Tiwari, S. Goyal
For the past few decades, a solid mass in the kidney with avid enhancement was considered renal cell carcinoma (RCC). With the advancement in radiological interventions, the understanding and treatment of a large number of tumours has changed. Oncocytomas are solid benign renal masses contributing 3-7% in all renal neoplasms. We report a case of a 32-year-old male who presented to our medicine OPD with abdominal pain and discomfort for about one month, later diagnosed with oncocytoma. We emphasize the importance of the typical imaging findings for the diagnosis and characterization of renal tumors.
{"title":"Typical Imaging Findings of Renal Oncocytoma","authors":"B. Dua, Rajaram Sharma, T. Tiwari, S. Goyal","doi":"10.29245/2572-9411/2022/1.1203","DOIUrl":"https://doi.org/10.29245/2572-9411/2022/1.1203","url":null,"abstract":"For the past few decades, a solid mass in the kidney with avid enhancement was considered renal cell carcinoma (RCC). With the advancement in radiological interventions, the understanding and treatment of a large number of tumours has changed. Oncocytomas are solid benign renal masses contributing 3-7% in all renal neoplasms. We report a case of a 32-year-old male who presented to our medicine OPD with abdominal pain and discomfort for about one month, later diagnosed with oncocytoma. We emphasize the importance of the typical imaging findings for the diagnosis and characterization of renal tumors.","PeriodicalId":91764,"journal":{"name":"Journal of rare diseases research & treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81799886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-12-10DOI: 10.29245/2572-9411/2021/2.1202
M. Niasse, A. Ndao, Ramadhane Bouchrane, S. Charifah, A. Bah, S. Diallo
Ankylosing spondylitis is the most common type of spondyloarthritis1, a group of diseases characterized by axial skeleton and sacroiliac involvement, peripheral joints and/or entheseal involvement and extra-articular manifestations1,2. Other types of spondyloarthritis are psoriatic arthritis, reactive arthritis, arthritis associated with cryptogenetic inflammatory bowel disease, S.A.P.H.O. (Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis), juvenile spondyloarthritis and undifferentiated forms. All other forms of spondyloarthritis can develop into ankylosing spondylitis1,2. This form, which can also occur at the outset, is characterized by the presence of sacroiliitis, often associated with stiffness and spinal deformities1,2,3.
{"title":"Ankylosing Spondylitis associated with Adult Still's Disease: The First Senegalese Case Report","authors":"M. Niasse, A. Ndao, Ramadhane Bouchrane, S. Charifah, A. Bah, S. Diallo","doi":"10.29245/2572-9411/2021/2.1202","DOIUrl":"https://doi.org/10.29245/2572-9411/2021/2.1202","url":null,"abstract":"Ankylosing spondylitis is the most common type of spondyloarthritis1, a group of diseases characterized by axial skeleton and sacroiliac involvement, peripheral joints and/or entheseal involvement and extra-articular manifestations1,2. Other types of spondyloarthritis are psoriatic arthritis, reactive arthritis, arthritis associated with cryptogenetic inflammatory bowel disease, S.A.P.H.O. (Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis), juvenile spondyloarthritis and undifferentiated forms. All other forms of spondyloarthritis can develop into ankylosing spondylitis1,2. This form, which can also occur at the outset, is characterized by the presence of sacroiliitis, often associated with stiffness and spinal deformities1,2,3.","PeriodicalId":91764,"journal":{"name":"Journal of rare diseases research & treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85848622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-07-05DOI: 10.29245/2572-9411/2021/1.1200
M. Mukaddam, K. Cheung, Sammi Kile, Michelle R. Davis, F. Kaplan, R. Pignolo
Background:Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare disease characterized by malformed great toes and progressive heterotopic ossification (HO) in soft tissues. Current standard-of-care is aimed at palliation of symptoms; there are no currently approved therapies to prevent HO. Recurrent episodes of HO starting in early life lead to cumulative disability, severe functional limitations, and shortened life span. Most individuals require assistive devices and extensive caregiver support before the second decade of life. Caregiver support is thought to be high, but the timing and extent of caregiver support in FOP has not been formally assessed. Methods: Using data from the International FOP Association (IFOPA) Global Registry on 299 patients (median age 21 years; range 0.1 to 78 years) from 54 countries, we characterized the extent of caregiver support by assessing the number of part-time and full-time caregivers and school aides reported by participants, based on age. Results: Over 50% of FOP Registry respondents reported a need for part-time or full-time home personal care attendants. The percentage of individuals who reported a requirement for bathing attendants and part- or full-time home personal care attendants increased with age (>1 part-time or full-time caregiver exceeded 30% for individuals >15 years of age), as did the number of part-time or full-time attendants. Support from school aides peaked between 9 and 15 years of age. Conclusion: Caregiver support in FOP is high in terms of time and amount of support needed, increases rapidly with age, and is substantial by the second decade of life. These findings highlight the urgent need for transformative treatments that will preserve the independence of individuals with FOP.
{"title":"Caregiver Support in Fibrodysplasia Ossificans Progressiva","authors":"M. Mukaddam, K. Cheung, Sammi Kile, Michelle R. Davis, F. Kaplan, R. Pignolo","doi":"10.29245/2572-9411/2021/1.1200","DOIUrl":"https://doi.org/10.29245/2572-9411/2021/1.1200","url":null,"abstract":"Background:Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare disease characterized by malformed great toes and progressive heterotopic ossification (HO) in soft tissues. Current standard-of-care is aimed at palliation of symptoms; there are no currently approved therapies to prevent HO. Recurrent episodes of HO starting in early life lead to cumulative disability, severe functional limitations, and shortened life span. Most individuals require assistive devices and extensive caregiver support before the second decade of life. Caregiver support is thought to be high, but the timing and extent of caregiver support in FOP has not been formally assessed. Methods: Using data from the International FOP Association (IFOPA) Global Registry on 299 patients (median age 21 years; range 0.1 to 78 years) from 54 countries, we characterized the extent of caregiver support by assessing the number of part-time and full-time caregivers and school aides reported by participants, based on age. Results: Over 50% of FOP Registry respondents reported a need for part-time or full-time home personal care attendants. The percentage of individuals who reported a requirement for bathing attendants and part- or full-time home personal care attendants increased with age (>1 part-time or full-time caregiver exceeded 30% for individuals >15 years of age), as did the number of part-time or full-time attendants. Support from school aides peaked between 9 and 15 years of age. Conclusion: Caregiver support in FOP is high in terms of time and amount of support needed, increases rapidly with age, and is substantial by the second decade of life. These findings highlight the urgent need for transformative treatments that will preserve the independence of individuals with FOP.","PeriodicalId":91764,"journal":{"name":"Journal of rare diseases research & treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80464910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-07-01DOI: 10.29245/2572-9411/2020/2.1191
Zainab Almasseri, Manal Jilwan, A. Almadani, M. Al-Owain, R. Gama, R. Sulaiman
Prolactinoma as a Cause of Persistent Hyperprolactinemia in 6-Pyruvoyl-tetrahydropterin synthase Deficiency Zainab Almasseri1, Manal NicolasJilwan2, Ahmad Khaled Almadani1, Mohammad Al-Owain1,5, Rousseau Gama3,4, Raashda Ainuddin Sulaiman1,5* 1Department of Medical Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia 2Department of Radiology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia 3Blood sciences, The Royal Wolverhampton NHS trust, Wolverhampton, UK. 4School of Medicine and Clinical Practice, Wolverhampton University, UK 5College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
催乳素瘤是6-Pyruvoyl-tetrahydropterin synthase缺乏症患者持续高催乳素血症的原因Zainab Almasseri1, Manal NicolasJilwan2, Ahmad Khaled Almadani1, Mohammad Al-Owain1,5, Rousseau gam3,4, Raashda Ainuddin Sulaiman1,5* 1沙特阿拉伯利雅得费萨尔国王专科医院和研究中心医学遗传学部2沙特阿拉伯利雅得费萨尔国王专科医院和研究中心放射科3血液科学皇家伍尔弗汉普顿NHS信托，伍尔弗汉普顿，英国。4英国伍尔弗汉普顿大学医学与临床实践学院5沙特阿拉伯利雅得阿尔费萨尔大学医学院
{"title":"Prolactinoma as a Cause of Persistent Hyperprolactinemia in 6-Pyruvoyl-tetrahydropterin synthase Deficiency","authors":"Zainab Almasseri, Manal Jilwan, A. Almadani, M. Al-Owain, R. Gama, R. Sulaiman","doi":"10.29245/2572-9411/2020/2.1191","DOIUrl":"https://doi.org/10.29245/2572-9411/2020/2.1191","url":null,"abstract":"Prolactinoma as a Cause of Persistent Hyperprolactinemia in 6-Pyruvoyl-tetrahydropterin synthase Deficiency Zainab Almasseri1, Manal NicolasJilwan2, Ahmad Khaled Almadani1, Mohammad Al-Owain1,5, Rousseau Gama3,4, Raashda Ainuddin Sulaiman1,5* 1Department of Medical Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia 2Department of Radiology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia 3Blood sciences, The Royal Wolverhampton NHS trust, Wolverhampton, UK. 4School of Medicine and Clinical Practice, Wolverhampton University, UK 5College of Medicine, Alfaisal University, Riyadh, Saudi Arabia","PeriodicalId":91764,"journal":{"name":"Journal of rare diseases research & treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88759345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01DOI: 10.29245/2572-9411/2020/1.1190
P. Kulkarni, Aarti Sevilimedu
Fragile X Syndrome (FXS) is a rare disease and the leading monogenic cause of Autism Spectrum Disorders (ASD). It is caused by the silencing of the Fragile X mental retardation (FMR1) gene and the subsequent reduction or loss of fragile X mental retardation protein (FMRP). The clinical effects seen in FXS patients are several and highly variable making it difficult to model them in a single model or even one organism. Furthermore, several human behaviours can be measured only through surrogate endpoints in animals. Therefore, it has been challenging to develop in vivo models of FXS for drug discovery.
{"title":"The Known Unknowns: Missing Pieces in in vivo Models of Fragile X Syndrome","authors":"P. Kulkarni, Aarti Sevilimedu","doi":"10.29245/2572-9411/2020/1.1190","DOIUrl":"https://doi.org/10.29245/2572-9411/2020/1.1190","url":null,"abstract":"Fragile X Syndrome (FXS) is a rare disease and the leading monogenic cause of Autism Spectrum Disorders (ASD). It is caused by the silencing of the Fragile X mental retardation (FMR1) gene and the subsequent reduction or loss of fragile X mental retardation protein (FMRP). The clinical effects seen in FXS patients are several and highly variable making it difficult to model them in a single model or even one organism. Furthermore, several human behaviours can be measured only through surrogate endpoints in animals. Therefore, it has been challenging to develop in vivo models of FXS for drug discovery.","PeriodicalId":91764,"journal":{"name":"Journal of rare diseases research & treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72799456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-01DOI: 10.29245/2572-9411/2019/3.1185
M. Niasse, B. S. Kane, A. Gaye, E. Ndiaye, I. Faye, M. Sow, Tafsir Ka, A. Diallo, A. Faye, S. Diallo
Malignant Degeneration into Chondrosarcoma of Multiple Exostosis Disease: The First Senegalese Case Report Moustapha Niasse1*, Baïdy Sy Kane2, Abdou Majib Gaye3, El Hadji Modou Ndiaye2, Ibrahima Faye4, Maïmouna Sow2, Tafsir Ngary Ka2, Alioune Badara Diallo2, Atoumane Faye2, Saïdou Diallo1 1Department of Rheumatology, Aristide Le Dantec Teaching Hospital; Cheikh Anta DIOP University of Dakar, Senegal 2Department of Internal Medicine, Aristide Le Dantec Teaching Hospital; Cheikh Anta DIOP University of Dakar, Senegal 3Department of Anatomy and pathology, Aristide Le Dantec Teaching Hospital; Cheikh Anta DIOP University of Dakar, Senegal 4Department of Radiology, Aristide Le Dantec Teaching Hospital; Cheikh Anta DIOP University of Dakar, Senegal
多发性外生骨病恶性变性为软骨肉瘤:塞内加尔首例报告Moustapha niass1 *， Baïdy Sy kan2, Abdou Majib gay3, El Hadji Modou ndiay2, Ibrahima Faye4, Maïmouna Sow2, Tafsir Ngary Ka2, Alioune Badara Diallo2, Atoumane Faye2, Saïdou Diallo12 aritide Le Dantec教学医院内科;3 aritide Le Dantec教学医院解剖病理教研室;4 aritide Le Dantec教学医院放射科;谢赫·安塔·迪奥普大学，塞内加尔
{"title":"Malignant Degeneration into Chondrosarcoma of Multiple Exostosis Disease: The First Senegalese Case Report","authors":"M. Niasse, B. S. Kane, A. Gaye, E. Ndiaye, I. Faye, M. Sow, Tafsir Ka, A. Diallo, A. Faye, S. Diallo","doi":"10.29245/2572-9411/2019/3.1185","DOIUrl":"https://doi.org/10.29245/2572-9411/2019/3.1185","url":null,"abstract":"Malignant Degeneration into Chondrosarcoma of Multiple Exostosis Disease: The First Senegalese Case Report Moustapha Niasse1*, Baïdy Sy Kane2, Abdou Majib Gaye3, El Hadji Modou Ndiaye2, Ibrahima Faye4, Maïmouna Sow2, Tafsir Ngary Ka2, Alioune Badara Diallo2, Atoumane Faye2, Saïdou Diallo1 1Department of Rheumatology, Aristide Le Dantec Teaching Hospital; Cheikh Anta DIOP University of Dakar, Senegal 2Department of Internal Medicine, Aristide Le Dantec Teaching Hospital; Cheikh Anta DIOP University of Dakar, Senegal 3Department of Anatomy and pathology, Aristide Le Dantec Teaching Hospital; Cheikh Anta DIOP University of Dakar, Senegal 4Department of Radiology, Aristide Le Dantec Teaching Hospital; Cheikh Anta DIOP University of Dakar, Senegal","PeriodicalId":91764,"journal":{"name":"Journal of rare diseases research & treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80520184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-07-01DOI: 10.29245/2572-9411/2019/3.1175
Ana Paula Vanz, T. Félix, N. S. Rocha, I. Schwartz
Commentary: “Quality of Life in Caregivers of Children and Adolescents with Osteogenesis Imperfecta” Ana Paula Vanz1, Têmis Maria Félix2,3, Neusa Sica da Rocha4, Ida Vanessa D. Schwartz2,5* 1Nurse department, Faculdades Integradas de Taquara, Taquara, Brazil 2Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil 3Postgraduate Program in Child and Adolescent Health, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil 4Postgraduate Program in Medical Sciences: Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil 5Department of Genetics, Universidade Federal do Rio Grande do Sul, Brazil
评论:“成骨不全儿童和青少年护理人员的生活质量”Ana Paula Vanz1, Têmis Maria f， 2,3, Neusa Sica da Rocha4, Ida Vanessa D. schwartz2,5 * 1护理部，Taquara综合学院，Taquara, Taquara，巴西2医学遗传学服务，Clínicas de de Alegre Porto，巴西3儿童和青少年健康研究生课程，南里奥格兰德州联邦大学，巴西4医学科学研究生课程;南里奥格兰德州联邦大学精神病学，阿雷格里港，巴西5南里奥格兰德州联邦大学遗传学系，巴西
{"title":"Commentary: \"Quality of Life in Caregivers of Children and Adolescents with Osteogenesis Imperfecta\"","authors":"Ana Paula Vanz, T. Félix, N. S. Rocha, I. Schwartz","doi":"10.29245/2572-9411/2019/3.1175","DOIUrl":"https://doi.org/10.29245/2572-9411/2019/3.1175","url":null,"abstract":"Commentary: “Quality of Life in Caregivers of Children and Adolescents with Osteogenesis Imperfecta” Ana Paula Vanz1, Têmis Maria Félix2,3, Neusa Sica da Rocha4, Ida Vanessa D. Schwartz2,5* 1Nurse department, Faculdades Integradas de Taquara, Taquara, Brazil 2Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil 3Postgraduate Program in Child and Adolescent Health, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil 4Postgraduate Program in Medical Sciences: Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil 5Department of Genetics, Universidade Federal do Rio Grande do Sul, Brazil","PeriodicalId":91764,"journal":{"name":"Journal of rare diseases research & treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80263601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-04-01DOI: 10.29245/2572-9411/2019/2.1177
Gang-ping Wang
Metastatic carcinomas to the testis are extremely rare and have been reported only in autopsy series or case reports. However, when they occur, the metastatic tumors in the testis are usually unilateral and solitary, may have overlap growth patterns and cytological features with primary testicular tumors, including those of rete/epididymis origin, mesothelial origin and Sertoli cell tumor. It will make the diagnosis very challenging, especially when there is no known history of a primary tumor in other sites. Metastatic prostatic adenocarcinoma counts nearly half of the overall metastatic carcinoma in the testis, followed by colorectal carcinoma and renal cell carcinoma. Here, we review our experience and summarize the reported cases from the literature, to emphasize some of the unusual aspects of metastatic carcinoma to the testis, and discuss the main differential diagnoses for this rare condition. Awareness of the features of these tumors, consideration of the possibility of metastasis and appropriate ancillary studies are the keys to the accurate diagnosis of these cases.
{"title":"Metastatic Carcinoma to the Testis - A Mini Review","authors":"Gang-ping Wang","doi":"10.29245/2572-9411/2019/2.1177","DOIUrl":"https://doi.org/10.29245/2572-9411/2019/2.1177","url":null,"abstract":"Metastatic carcinomas to the testis are extremely rare and have been reported only in autopsy series or case reports. However, when they occur, the metastatic tumors in the testis are usually unilateral and solitary, may have overlap growth patterns and cytological features with primary testicular tumors, including those of rete/epididymis origin, mesothelial origin and Sertoli cell tumor. It will make the diagnosis very challenging, especially when there is no known history of a primary tumor in other sites. Metastatic prostatic adenocarcinoma counts nearly half of the overall metastatic carcinoma in the testis, followed by colorectal carcinoma and renal cell carcinoma. Here, we review our experience and summarize the reported cases from the literature, to emphasize some of the unusual aspects of metastatic carcinoma to the testis, and discuss the main differential diagnoses for this rare condition. Awareness of the features of these tumors, consideration of the possibility of metastasis and appropriate ancillary studies are the keys to the accurate diagnosis of these cases.","PeriodicalId":91764,"journal":{"name":"Journal of rare diseases research & treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83031495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-04-01DOI: 10.29245/2572-9411/2019/2.1172
Boris Ariel, I. Dvorakovskaya, L. Novikova, M. Ilkovich
{"title":"http://www.rarediseasesjournal.com/old-issues.php?journal=jrdrt&&v=4&&i=2&&y=2019&&m=April","authors":"Boris Ariel, I. Dvorakovskaya, L. Novikova, M. Ilkovich","doi":"10.29245/2572-9411/2019/2.1172","DOIUrl":"https://doi.org/10.29245/2572-9411/2019/2.1172","url":null,"abstract":"","PeriodicalId":91764,"journal":{"name":"Journal of rare diseases research & treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85582793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-04-01DOI: 10.29245/2572-9411/2019/2.1181
A. Migliore, G. Gigliucci, S. Tormenta, A. Cata, L. Gallelli, G. Iolascon
High Molecular Weight Hyaluronic Acid (Hyalubrix/HyalOne) for Treating Symptomatic Hip Osteoarthritis Alberto Migliore1*, Gianfranco Gigliucci1, Sandro Tormenta2, Angelo De Cata3, Luca Gallelli4, Giovanni Iolascon5 1Rheumatology Unit and Research Center, S. Pietro Fatebenefratelli Hospital, Rome, Italy 2Radiology Unit, S. Pietro Fatebenefratelli Hospital, Rome, Italy 3Department of Medical Sciences, Division of Internal Medicine and Rheumatology Unit, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo (FG), Italy 4Chair of Pharmacology Department of Health Science, University of Catanzaro School of Medicine, and Operative Unit of Clinical Pharmacology and Pharmacovigilance, Azienda Ospedaliera MaterDomini, Catanzaro, Italy 5Department of Medical and Surgical Specialties and Dentistry, University of Campania “Luigi Vanvitelli”, Naples, Italy
高分子透明质酸(hyalbrix /HyalOne)治疗症状性髋关节骨关节炎Alberto Migliore1*， Gianfranco Gigliucci1, Sandro torment2, Angelo De cat3, Luca Gallelli4, Giovanni Iolascon5 1意大利罗马S. Pietro Fatebenefratelli医院风湿病科和研究中心2意大利罗马S. Pietro Fatebenefratelli医院放射科3内科和风湿病科医学学部;IRCCS Casa Sollievo della Sofferenza医院，San Giovanni Rotondo (FG)，意大利4卡坦扎罗大学医学院药理学系主任，临床药理学和药物警戒手术单元，意大利卡坦扎罗，意大利5意大利那不勒斯坎帕尼亚大学“Luigi Vanvitelli”医学和外科专业和牙科学系
{"title":"High Molecular Weight Hyaluronic Acid (Hyalubrix/HyalOne) for Treating Symptomatic Hip Osteoarthritis","authors":"A. Migliore, G. Gigliucci, S. Tormenta, A. Cata, L. Gallelli, G. Iolascon","doi":"10.29245/2572-9411/2019/2.1181","DOIUrl":"https://doi.org/10.29245/2572-9411/2019/2.1181","url":null,"abstract":"High Molecular Weight Hyaluronic Acid (Hyalubrix/HyalOne) for Treating Symptomatic Hip Osteoarthritis Alberto Migliore1*, Gianfranco Gigliucci1, Sandro Tormenta2, Angelo De Cata3, Luca Gallelli4, Giovanni Iolascon5 1Rheumatology Unit and Research Center, S. Pietro Fatebenefratelli Hospital, Rome, Italy 2Radiology Unit, S. Pietro Fatebenefratelli Hospital, Rome, Italy 3Department of Medical Sciences, Division of Internal Medicine and Rheumatology Unit, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo (FG), Italy 4Chair of Pharmacology Department of Health Science, University of Catanzaro School of Medicine, and Operative Unit of Clinical Pharmacology and Pharmacovigilance, Azienda Ospedaliera MaterDomini, Catanzaro, Italy 5Department of Medical and Surgical Specialties and Dentistry, University of Campania “Luigi Vanvitelli”, Naples, Italy","PeriodicalId":91764,"journal":{"name":"Journal of rare diseases research & treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80217468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：